A Prospective, Randomized, Multicentre, Comparative and Open-Label Study on Hepatotoxicity of ARIMIDEX Compared With Tamoxifen in Adjuvant Therapy in Postmenopausal Women With Hormone Receptor+ Early Breast Cancer.
Phase of Trial: Phase IV
Latest Information Update: 01 Sep 2014
At a glance
- Drugs Anastrozole (Primary) ; Tamoxifen
- Indications Early breast cancer
- Focus Adverse reactions
- Acronyms HEART
- Sponsors AstraZeneca
- 03 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Oct 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 18 Oct 2011 Planned end date changed from 1 Mar 2012 to 1 Dec 2011 as reported by ClinicalTrials.gov.